Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Current Assets (2012 - 2026)

Updated

Grace Therapeutics' Current Assets was $21.96 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), up 27.0% from $17.3 million a year earlier and up 53.2% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Current Assets (2012 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Current Assets at Grace Therapeutics came in at $17.38 million, down 23.5% from FY2025.

  • Current Assets has now declined for five consecutive fiscal years, with a five-year compound annual growth rate of -22.6% (FY2021 to FY2026).
  • In earlier fiscal years, Current Assets was $22.71 million in FY2025 (-5.4%), $24.01 million in FY2024 (-18.0%), $29.29 million in FY2023 (-35.3%) and $45.28 million in FY2022 (-27.4%).
  • The fiscal Q2 2027 figure marks the highest quarterly Current Assets since fiscal Q4 2025.
  • Compared with a year earlier, Current Assets was higher in four of the last eight quarters, with an average decline of 2.3%.
  • The best year-over-year quarter for Current Assets over five years was fiscal Q3 2022 (growth of 62.3%); the worst was fiscal Q3 2025 (a decline of 55.6%).
  • Per Business Quant data, GRCE's Current Assets in the three fiscal quarters before Q2 2027 was $14.33 million (Q1 2027), $17.38 million (Q4 2026) and $19.21 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 65.26 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 56.35 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 37.48 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 38.94 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 31.45 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 34.36 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 16.55 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 45.01 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - 21.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 21.96 Mn
Jun 30, 2026 14.33 Mn
Mar 31, 2026 17.38 Mn
Dec 31, 2025 19.21 Mn
Sep 30, 2025 17.30 Mn
Jun 30, 2025 20.53 Mn
Mar 31, 2025 22.71 Mn
Dec 31, 2024 11.94 Mn
Sep 30, 2024 16.06 Mn
Jun 30, 2024 20.43 Mn
Mar 31, 2024 24.01 Mn
Dec 31, 2023 26.88 Mn
Sep 30, 2023 28.89 Mn
Jun 30, 2023 23.61 Mn
Mar 31, 2023 29.29 Mn
Dec 31, 2022 33.43 Mn
Sep 30, 2022 37.51 Mn
Jun 30, 2022 41.25 Mn
Mar 31, 2022 45.28 Mn
Dec 31, 2021 49.00 Mn
API Access

Grace Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=GRCE&period=max&api_key=YOUR_API_KEY